These clinical data, suggesting a potential role of the degree of cortisol secretion and sensitivity in the T2DM-related bone osteoporosis, are in line with recent in vitro data showing that the shift in the balance between osteoblastogenesis and adipogenesis of MSC may be mediated by the GR genetic variants [151]. This evidence concerns the gene NR3C1 and type 2 diabetes mellitus.